Related Experiment Video
Updated: Apr 14, 2026
06:54
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
3.5K
Matrix metalloproteinases as therapeutic targets for stroke
1Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.
Brain Research
|April 29, 2015
Summary
Matrix metalloproteinases (MMPs) play a dual role in ischemic injury, causing damage early on and aiding recovery later. Understanding these enzymes is key for developing effective stroke treatments.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Matrix metalloproteinases (MMPs) are enzymes that degrade the extracellular matrix (ECM).
- MMPs are secreted in a latent form and activated upon specific triggers.
- Tissue inhibitors of metalloproteinases (TIMPs) inactivate MMPs.
Purpose of the Study:
- To explore the complex roles of MMPs in ischemic injury and recovery.
- To understand the dual function of MMPs in early injury and later repair phases.
- To highlight the challenges in developing MMP-targeted stroke therapies.
Main Methods:
- Review of existing literature on MMPs in ischemic injury.
- Analysis of the activation mechanisms of constitutive (MMP-2, MMP-14) and inducible (MMP-3, MMP-9) MMPs.
- Discussion of MMPs' interactions with extracellular matrix components and inflammatory processes.
Main Results:
- MMPs contribute to both the initial injury and subsequent repair processes in ischemic conditions.
- Constitutive MMPs are activated spatially specifically, while inducible MMPs are activated during neuroinflammation.
- The dual role of MMPs complicates therapeutic strategies for stroke.
Conclusions:
- MMPs exhibit complex, context-dependent functions in ischemic injury and recovery.
- Targeting MMPs for stroke treatment requires careful consideration of their beneficial and detrimental effects.
- Further research is needed to elucidate MMPs' precise roles in different stages of stroke for optimized therapeutic interventions.
